S100B and Stroke: At the onset of any neurodegenerative disorders such as Alzheimer’s, Down’s syndrome, trauma, brain injury, myocardial infarction and stroke, there is an increase in the concentration of S100β proteins which serves as a biomarker for clinical purposes [1].